BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8777715)

  • 1. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate.
    Cyster JG; Goodnow CC
    Immunity; 1995 Dec; 3(6):691-701. PubMed ID: 8777715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirements for follicular exclusion and competitive elimination of autoantigen-binding B cells.
    Ekland EH; Forster R; Lipp M; Cyster JG
    J Immunol; 2004 Apr; 172(8):4700-8. PubMed ID: 15067045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced life span of anergic self-reactive B cells in a double-transgenic model.
    Fulcher DA; Basten A
    J Exp Med; 1994 Jan; 179(1):125-34. PubMed ID: 8270860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells.
    Schmidt KN; Cyster JG
    J Immunol; 1999 Jan; 162(1):284-91. PubMed ID: 9886397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.
    Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R
    J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.
    Eris JM; Basten A; Brink R; Doherty K; Kehry MR; Hodgkin PD
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4392-6. PubMed ID: 7514304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy.
    Cook MC; Basten A; Fazekas de St Groth B
    J Exp Med; 1997 Aug; 186(5):631-43. PubMed ID: 9271579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of self-reactive B cells by provision of T cell help in vivo.
    Cook MC; Basten A; Fazekas de St Groth B
    Eur J Immunol; 1998 Aug; 28(8):2549-58. PubMed ID: 9710232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens.
    Akerlund J; Getahun A; Cambier JC
    J Autoimmun; 2015 Aug; 62():45-54. PubMed ID: 26152931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
    Kanost D; McCluskey J
    Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance.
    Yan J; Mamula MJ
    J Immunol; 2002 Apr; 168(7):3188-94. PubMed ID: 11907071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.
    Fulcher DA; Lyons AB; Korn SL; Cook MC; Koleda C; Parish C; Fazekas de St Groth B; Basten A
    J Exp Med; 1996 May; 183(5):2313-28. PubMed ID: 8642340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells.
    Rathmell JC; Cooke MP; Ho WY; Grein J; Townsend SE; Davis MM; Goodnow CC
    Nature; 1995 Jul; 376(6536):181-4. PubMed ID: 7603571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
    Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
    J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors.
    Feuerstein N; Shivers D; Chen F; Eisenberg RA; Finkel TH
    Int Immunol; 2003 Aug; 15(8):975-85. PubMed ID: 12882835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.
    Ho WY; Cooke MP; Goodnow CC; Davis MM
    J Exp Med; 1994 May; 179(5):1539-49. PubMed ID: 7909325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.
    Rathmell JC; Fournier S; Weintraub BC; Allison JP; Goodnow CC
    J Exp Med; 1998 Aug; 188(4):651-9. PubMed ID: 9705947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.
    Chackerian B; Durfee MR; Schiller JT
    J Immunol; 2008 May; 180(9):5816-25. PubMed ID: 18424700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.